We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Quantum Phar. | LSE:QP. | London | Ordinary Share | GB00BRTL8Q42 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.2374 | 84.00 | 84.75 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMQP. TIDMAV.
RNS Number : 1383P
Quantum Pharma PLC
14 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ------------------------------------------------------------------------------------------------------------ 1. Identity of the issuer or Quantum Pharma plc the underlying issuer of existing shares to which voting rights are attached: --------------------------------------------------------------- ------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights ---------------------------------------------------------------------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------------------------------------------------- An event changing the breakdown of voting rights ---------------------------------------------------------------------------------------------------------- Other (please CHANGE TO THE NUMBER OF VOTING RIGHTS specify): IN ISSUE, FOLLOWING THE RECENT PLACING. ----------------------------------------------------------- --------------------------------------------- 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: ------------------------------------------------------------- --------------------------------------------- 4. Full name of shareholder(s) Registered Holder: (if different from 3.): BNY Norwich Union Nominees Limited 282,753* Chase (GA Group) Nominees Limited 6,402,583* State Street Nominees Limited 1,232,291* *denotes direct interest Chase Nominees Limited 203,374 ------------------------------------------------------------- --------------------------------------------- 5. Date of the transaction 11 November 2016 and date on which the threshold is crossed or reached: ------------------------------------------------------------- --------------------------------------------- 6. Date on which issuer 14 November 2016 notified: ------------------------------------------------------------- --------------------------------------------- 7. Threshold(s) that is/are 6% to 4% Change at Direct crossed or Interest Level reached: >5% to <5% Change at Combined Interest Level ------------------------------------------------------------- --------------------------------------------- 8. Notified details: ----------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ----------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------------- ------------------------------- ----------------------------------------------------- Number Number Number Number of % of voting of of of voting rights Shares Voting shares rights Rights ------------------- ------------------- ---------- ---------- --------------------- ------------------ Direct Direct Indirect Direct Indirect ------------------- ------------------- ---------- ---------- ---------- --------- ------- --------- Ordinary Shares GB00BRTL8Q42 8,910,561 8,910,561 8,121,001 7,917,627 203,374 4.68% 0.12% ------------------- ---------- ---------- ---------- --------- ------- --------- B: Qualifying Financial Instruments ----------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights Period may be acquired if the instrument is exercised/ converted. ------------------- ------------------- ---------------------- --------------------- ------------------ 297,000* RIGHT TO RECALL LOANED SHARES N/A N/A *Direct interest 0.18% ------------------- ------------------- ---------------------- --------------------- ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights period refers to ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 8,418,001 4.98% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ------------------------------------------------------------------------------------ The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Proxy Voting: ------------------------------------------------------------------------------------ 10. Name of the proxy holder: See Section 4 --------------------------------------------- ------------------------------------- 11. Number of voting rights proxy holder will cease to hold: --------------------------------------------- ------------------------------------- 12. Date on which proxy holder will cease to hold voting rights: --------------------------------------------- ------------------------------------- 13. Additional information: Figures are based on a total number of voting rights of 169,117,640 as per the Company's
'Result of General Meeting & Total Voting Rights' announcement of 10 November 2016. --------------------------------------------- ------------------------------------- 14. Contact name: Neil Whittaker, Aviva plc --------------------------------------------- ------------------------------------- 15. Contact telephone number: 01603 684420 --------------------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGGQGGUPQGQC
(END) Dow Jones Newswires
November 14, 2016 11:20 ET (16:20 GMT)
1 Year Quantum Phar. Chart |
1 Month Quantum Phar. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions